We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+10.11%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$47.1B
AUM Growth
+$2.61B
(+5.9%)
Cap. Flow
-$501M
Cap. Flow
% of AUM
-1.06%
Top 10 Holdings %
Top 10 Hldgs %
14.43%
Holding
3,576
New
705
Increased
706
Reduced
825
Closed
988
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$417M |
| 2 |
Meta Platforms (Facebook)
META
|
+$383M |
| 3 |
Amazon
AMZN
|
+$308M |
| 4 |
Microsoft
MSFT
|
+$293M |
| 5 |
GE Aerospace
GE
|
+$263M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$312M |
| 2 |
Bank of America
BAC
|
+$292M |
| 3 |
ExxonMobil
XOM
|
+$274M |
| 4 |
lululemon athletica
LULU
|
+$238M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.05% |
| 2 | Technology | 14.35% |
| 3 | Consumer Discretionary | 13.97% |
| 4 | Financials | 9.9% |
| 5 | Industrials | 6.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Enbridge
ENB
$124B
| $27.1M | 0.06% |
+710,581
| New | +$27.9M |
|
352
Martin Marietta Materials
MLM
$33.6B
| $27.1M | 0.06% |
76,230
-43,154
| -36% | -$15.1M |
|
353
CALL
Salesforce
CRM
$134B
| $27.1M | 0.06% |
135,400
+21,300
| +19% | +$3.6M |
|
354
Goldman Sachs
GS
$313B
| $27M | 0.06% |
82,659
-97,722
| -54% | -$34M |
|
355
Coeur Mining
CDE
$15.6B
| $27M | 0.06% |
+6,776,414
| New | +$23.5M |
|
356
Paylocity
PCTY
$6.71B
| $26.9M | 0.06% |
135,569
+59,424
| +78% | +$11.7M |
|
357
Trade Desk
TTD
$8.13B
| $26.7M | 0.06% |
439,129
+433,912
| +8,317% | +$23.1M |
|
358
LivaNova
LIVN
$4.3B
| $26.7M | 0.06% |
612,444
-296,247
| -33% | -$15M |
|
359
Equinor
EQNR
$95.9B
| $26.5M | 0.06% |
933,110
+925,710
| +12,510% | +$27.9M |
|
360
Carlisle Companies
CSL
$13.6B
| $26.4M | 0.06% |
116,756
-241,710
| -67% | -$58.8M |
|
361
PUT
Alibaba
BABA
$269B
| $26.2M | 0.06% |
256,800
+143,900
| +127% | +$14.4M |
|
362
Cytokinetics
CYTK
$11B
| $26.2M | 0.06% |
745,307
-266,155
| -26% | -$10.9M |
|
|
OPTU
363
Optimum Communications Inc
OPTU
$316M
| $26.2M | 0.06% |
7,663,030
-263,196
| -3% | -$1.12M |
|
364
GFL Environmental
GFL
$14.3B
| $26.1M | 0.06% |
+759,104
| New | +$24M |
|
365
PUT
iShares Silver Trust
SLV
$28.1B
| $26.1M | 0.06% |
+1,180,300
| New | +$24.4M |
|
366
Datadog
DDOG
$87.9B
| $25.9M | 0.05% |
+355,907
| New | +$26.1M |
|
367
PUT
Chevron
CVX
$388B
| $25.8M | 0.05% |
158,200
+51,700
| +49% | +$8.67M |
|
368
CALL
NVIDIA
NVDA
$5.01T
| $25.8M | 0.05% |
929,000
+366,000
| +65% | +$7.92M |
|
369
State Street Health Care Select Sector SPDR ETF
XLV
$42.1B
| $25.8M | 0.05% |
198,942
+132,176
| +198% | +$17.3M |
|
370
PUT
Starbucks
SBUX
$118B
| $25.6M | 0.05% |
+246,300
| New | +$25.6M |
|
371
Calix
CALX
$2.27B
| $25.6M | 0.05% |
476,790
+50,934
| +12% | +$2.78M |
|
372
Arcutis Biotherapeutics
ARQT
$3.42B
| $25.4M | 0.05% |
+2,305,336
| New | +$33.4M |
|
|
MGI
373
DELISTED
MoneyGram International, Inc. New
MGI
| $25.3M | 0.05% |
2,424,255
+125,525
| +5% | +$1.35M |
|
374
Occidental Petroleum
OXY
$57B
| $25.3M | 0.05% |
404,458
-536
| -0.1% | -$33.3K |
|
375
Citizens Financial Group
CFG
$30.4B
| $25.2M | 0.05% |
830,018
-1,394,019
| -63% | -$54.6M |
|
Similar funds
Marshall Wace's Q1 2023 Portfolio in Review
As of Q1 2023, Marshall Wace held 3,576 positions worth $47.1B, up 5.9% from $44.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Marshall Wace's Q1 2023 filing shows 705 new, 706 increased, 825 reduced and 988 closed positions. Its largest new stake was Madrigal Pharmaceuticals: 541,764 shares worth $131M. The largest sale was Cigna, an estimated $312M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- Marshall Wace's largest Q1 2023 buy was Madrigal Pharmaceuticals: 541,764 shares worth $131M.
- Marshall Wace added most to Walmart Inc in Q1 2023, an estimated $417M increase.
- Marshall Wace's biggest Q1 2023 reduction was Cigna, cutting an estimated $312M.
- Marshall Wace fully exited Merck in Q1 2023, selling an estimated $115M.
- Marshall Wace's ten largest holdings make up 14% of its $47.1B portfolio in Q1 2023.
- Marshall Wace opened 705 new positions and closed 988 in Q1 2023.
- Marshall Wace's portfolio value rose 5.9% quarter-over-quarter to $47.1B.
Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.